Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States

被引:15
|
作者
Bhatt, Neel S. [1 ]
Brazauskas, Ruta [2 ,3 ]
Salit, Rachel B. [1 ]
Syrjala, Karen [1 ]
Bo-Subait, Stephanie [4 ]
Tecca, Heather [2 ]
Badawy, Sherif M. [5 ,6 ]
Baker, K. Scott [1 ]
Beitinjaneh, Amer [7 ]
Bejanyan, Nelli [8 ]
Byrne, Michael [9 ]
Dias, Ajoy [10 ]
Farhadfar, Nosha [11 ]
Freytes, Cesar O. [12 ]
Ganguly, Siddhartha [13 ]
Hashmi, Shahrukh [14 ,15 ]
Hayashi, Robert J. [16 ]
Hong, Sanghee [17 ]
Inamoto, Yoshihiro [18 ]
Jamani, Kareem [19 ]
Kasow, Kimberly A. [20 ]
Khera, Nandita [21 ]
Krem, Maxwell M. [22 ]
Lazarus, Hillard M. [23 ]
Lee, Catherine J. [24 ]
Lee, Stephanie [1 ,2 ]
Majhail, Navneet S. [17 ]
Malone, Adriana K. [25 ]
Marks, David, I [26 ]
Mau, Lih-Wen [4 ]
Mayo, Samantha J. [27 ]
Muffly, Lori S. [28 ]
Nathan, Sunita [29 ]
Nishihori, Taiga [8 ]
Page, Kristin M. [30 ]
Preussler, Jaime [4 ]
Rangarajan, Hemalatha G. [31 ]
Rotz, Seth J. [32 ]
Salooja, Nina [33 ]
Savani, Bipin N. [34 ]
Schears, Raquel [35 ]
Schechter-Finkelstein, Tal [36 ]
Schiller, Gary [37 ]
Shah, Ami J. [38 ]
Sharma, Akshay [39 ]
Wang, Trent [7 ]
Wirk, Baldeep [40 ]
Battiwalla, Minoo [41 ]
Schoemans, Helene [42 ,43 ]
Hamilton, Betty [17 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Clin Res Div, 1100 Fairview Ave N,D5-390, Seattle, WA 98109 USA
[2] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA
[3] Med Coll Wisconsin, Inst Hlth & Equ, Div Biostat, Milwaukee, WI 53226 USA
[4] Ctr Int Blood & Marrow Transplant Res, Natl Marrow Donor Program Be Match, Minneapolis, MN USA
[5] Ann & Robert H Lurie Childrens Hosp Chicago, Div Hematol Oncol & Stem Cell Transplant, Chicago, IL 60611 USA
[6] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA
[7] Univ Miami, Div Transplantat & Cellular Therapy, Miami, FL USA
[8] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA
[9] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[10] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[11] Univ Florida, Coll Med, Div Hematol Oncol, Gainesville, FL USA
[12] Texas Transplant Inst, San Antonio, TX USA
[13] Univ Kansas Hlth Syst, Div Hematol Malignancy & Cellular Therapeut, Kansas City, KS USA
[14] Mayo Clin, Dept Internal Med, Rochester, MN USA
[15] Sheikh Shakhbout Med City, Dept Med, Abu Dhabi, U Arab Emirates
[16] Washington Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, St Louis, MO 63110 USA
[17] Cleveland Clin, Blood & Marrow Transplant Program, Taussig Canc Inst, Cleveland, OH 44106 USA
[18] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo, Japan
[19] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[20] Univ N Carolina, Chapel Hill, NC USA
[21] Mayo Clin, Dept Hematol Oncol, Phoenix, AZ USA
[22] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY USA
[23] Case Western Reserve Univ, Univ Hosp Cleveland Med Ctr, Cleveland, OH 44106 USA
[24] Univ Utah, Utah Blood & Marrow Transplant Program, Huntsman Canc Inst, Salt Lake City, UT USA
[25] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
[26] Univ Hosp Bristol NHS Trust, Adult Bone Marrow Transplant, Bristol, Avon, England
[27] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada
[28] Stanford Univ, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA
[29] Rush Univ, Sect Bone Marrow Transplant & Cell Therapy, Med Ctr, Chicago, IL USA
[30] Duke Univ, Div Pediat Blood & Marrow Transplantat, Med Ctr, Durham, NC USA
[31] Nationwide Childrens Hosp, Dept Pediat Hematol Oncol Blood & Marrow Transpla, Columbus, OH USA
[32] Cleveland Clin, Dept Pediat Hematol Oncol & Blood & Marrow Transp, Childrens Hosp, Cleveland, OH USA
[33] Imperial Coll London, London, England
[34] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA
[35] Univ Cent Florida, Dept Emergency Med, Orlando, FL 32816 USA
[36] Hosp Sick Children, Toronto, ON, Canada
[37] Univ Calif Los Angeles, David Geffen Sch Med, Hematol Malignancy Stem Cell Transplant Program, Los Angeles, CA 90095 USA
[38] Stanford Sch Med, Lucille Packard Childrens Hosp, Div Stem Cell Transplantat & Regenerat Med, Palo Alto, CA USA
[39] St Jude Childrens Res Hosp, Dept Bone Marrow Transplantat & Cellular Therapy, 332 N Lauderdale St, Memphis, TN 38105 USA
[40] Penn State Canc Inst, Bone Marrow Transplant Program, Hershey, PA USA
[41] Sarah Cannon Blood Canc Network, Nashville, TN USA
[42] Univ Hosp Leuven, Dept Hematol, Leuven, Belgium
[43] Katholieke Univ Leuven, Leuven, Belgium
[44] Childrens Hosp Orange Cty, Div Pediat Hematol, Orange, CA USA
来源
TRANSPLANTATION AND CELLULAR THERAPY | 2021年 / 27卷 / 08期
关键词
Hematopoietic cell transplantation; Return to work; Quality of life; Young adult; QUALITY-OF-LIFE; CHILDHOOD-CANCER-SURVIVOR; VERSUS-HOST-DISEASE; ADOLESCENT; RECIPIENTS; HEALTH; MARROW; EMPLOYMENT; EDUCATION; RECOVERY;
D O I
10.1016/j.jtct.2021.04.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Young adult (YA) survivors of allogeneic hematopoietic cell transplantation (HCT) are at risk for late psychosocial challenges, including the inability to return to work post-HCT. Work-related outcomes in this population remain understudied, however. We conducted this study to assess the post-HCT work status of survivors of allogeneic HCT who underwent HCT as YAs and to analyze the patient-, disease-, and HCT-related factors associated with their work status at 1 year post-HCT. Using Center for International Blood and Marrow Transplant Research data, we evaluated the post-HCT work status (full-time, part-time work, unemployed, or medical disability) of 1365 YA HCT survivors who underwent HCT between 2008 and 2015. Percentages of work status categories were reported at 4 time points: 6 months, 1 year, 2 years, and 3 years post-HCT. Percentages of post-HCT work status categories at the 1-year time point were also described in relation to survivors' pre-HCT work status categories. Factors associated with 1-year post-HCT work status (full-time or part-time work) were examined using logistic regression. From 6 months to 3 years post-HCT, the percentage of survivors working full-time increased from 18.3% to 50.7% and the percentage working part-time increased from 6.9% to 10.5%. Of patients in full-time work pre-HCT, 50% were unemployed or on medical disability at 1 year post-HCT. Female sex (odds ratio [OR], 0.55; 95% confidence interval [CI], 0.40 to 0.77), HCT Comorbidity Index score >= 3 (OR, 0.57; 95% CI, 0.39 to 0.82), pre-HCT unemployment (OR, 0.37; 95% CI, 0.24 to 0.56), medical disability (OR, 0.44; 95% CI, 0.28 to 0.70), development of grade III-IV acute graft-versus-host disease (OR, 0.52; 95% CI, 0.34 to 0.80), and relapse within 1 year post-HCT (OR, 0.34; 95% CI, 0.21 to 0.56) were associated with a lower likelihood of employment at 1 year post-HCT. Compared with myeloablative conditioning (MAC) with total body irradiation (TBI), MAC without TBI (OR, 1.71; 95% CI, 1.16 to 2.53) was associated with a greater likelihood of employment at 1 year post-HCT. Graduate school-level education (OR, 2.47; 95% CI, 1.49 to 4.10) was also associated with a greater likelihood of employment at 1 year post-HCT. Although the work status among YA HCT survivors continued to improve over time, a substantial subset became or remained unemployed or on medical disability. These findings underscore the need for effective interventions to support return to work in this population. (C) 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:679.e1 / 679.e8
页数:8
相关论文
共 50 条
  • [1] Prevalence and Determinants of Return to Work as a Patient-Centered Outcome in Survivors of Hematopoietic Cell Transplantation
    Bhatt, Neel S.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2022, 17 (06) : 228 - 242
  • [2] Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up
    Kurosawa, Saiko
    Yamaguchi, Takuhiro
    Mori, Ayako
    Matsuura, Tomoko
    Mori, Takehiko
    Tanaka, Masatsugu
    Kondo, Tadakazu
    Umemoto, Yukari
    Goto, Hideki
    Yoshioka, Satoshi
    Machida, Shinichiro
    Sato, Takahiko
    Katayama, Yuta
    Kato, Seiko
    Shono, Katsuhiro
    Mizuno, Ishikazu
    Fujiwara, Shin-ichiro
    Kohno, Akio
    Takahashi, Miyako
    Fukuda, Takahiro
    JOURNAL OF CANCER SURVIVORSHIP, 2022, 16 (05) : 1004 - 1015
  • [3] Prevalence and Determinants of Return to Work as a Patient-Centered Outcome in Survivors of Hematopoietic Cell Transplantation
    Neel S. Bhatt
    Current Hematologic Malignancy Reports, 2022, 17 : 228 - 242
  • [4] Psychological states and needs among post-allogeneic hematopoietic stem cell transplantation survivors
    Sun, Yanling
    Yan, Pu
    Xu, Duorong
    Zhong, Zhiyong
    Xu, Ting
    Xin, Wenjun
    Zhang, Xiangzhong
    Zhang, Jingwen
    CANCER MEDICINE, 2023, 12 (15): : 16637 - 16648
  • [5] Profiles of Work and Quality of Life among Young Adult Cancer Survivors
    Ghazal, Lauren V.
    Merriman, John D.
    Santacroce, Sheila J.
    Fletcher, Jason
    Wright, Fay
    Dickson, Victoria Vaughan
    WESTERN JOURNAL OF NURSING RESEARCH, 2023, 45 (04) : 293 - 305
  • [6] Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation
    Kirchhoff, Anne C.
    Leisenring, Wendy
    Syrjala, Karen L.
    JOURNAL OF CANCER SURVIVORSHIP-RESEARCH AND PRACTICE, 2010, 4 (01): : 33 - 44
  • [7] Occupational status among adult survivors following allogeneic stem cell transplantation in childhood
    Winterling, Jeanette
    Johansson, Eva
    Wettergren, Lena
    Ljungman, Per
    Alexanderson, Kristina
    EUROPEAN JOURNAL OF CANCER CARE, 2018, 27 (02)
  • [8] Home-Based Hematopoietic Cell Transplantation in the United States
    Sung, Anthony D.
    Giri, Vinay K.
    Tang, Helen
    Nichols, Krista Rowe
    Lew, Meagan, V
    Bohannon, Lauren
    Ren, Yi
    Jung, Sin-Ho
    Dalton, Tara
    Bush, Amy
    Van Opstal, Jolien
    Artica, Alexandra
    Messina, Julia
    Shelby, Rebecca
    Frith, Jennifer
    Lassiter, Martha
    Burleson, Jill
    Leonard, Kari
    Potter, Ashley S.
    Choi, Taewoong
    Gasparetto, Cristina J.
    Horwitz, Mitchell E.
    Long, Gwynn D.
    Lopez, Richard D.
    Sarantopoulos, Stefanie
    Chao, Nelson J.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (04): : 207.e1 - 207.e8
  • [9] Fatigue predicts impaired social adjustment in survivors of allogeneic hematopoietic cell transplantation (HCT)
    Park, Jumin
    Wehrlen, Leslie
    Mitchell, Sandra A.
    Yang, Li
    Bevans, Margaret F.
    SUPPORTIVE CARE IN CANCER, 2019, 27 (04) : 1355 - 1363
  • [10] Young adult cancer survivors and work: a systematic review
    Stone, Dawn S.
    Ganz, Patricia A.
    Pavlish, Carol
    Robbins, Wendie A.
    JOURNAL OF CANCER SURVIVORSHIP, 2017, 11 (06) : 765 - 781